perhexiline has been researched along with Hyperlipoproteinemia Type II in 1 studies
Perhexiline: 2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis.
Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Y | 1 |
| Fan, Y | 1 |
| Zhang, J | 2 |
| Lomberk, GA | 1 |
| Zhou, Z | 1 |
| Sun, L | 1 |
| Mathison, AJ | 1 |
| Garcia-Barrio, MT | 1 |
| Zeng, L | 1 |
| Li, L | 1 |
| Pennathur, S | 1 |
| Willer, CJ | 1 |
| Rader, DJ | 1 |
| Urrutia, R | 1 |
| Chen, YE | 1 |
1 other study available for perhexiline and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.
Topics: Animals; Apolipoprotein A-I; Apolipoproteins E; Atherosclerosis; Cholesterol; Cholesterol, HDL; Diet | 2015 |